<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C33876E8-7958-41F0-87A6-095798CF94F9"><gtr:id>C33876E8-7958-41F0-87A6-095798CF94F9</gtr:id><gtr:name>Academy of Sciences of the Czech Republic</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/EA377C44-230F-49AB-9191-92C561B03AB8"><gtr:id>EA377C44-230F-49AB-9191-92C561B03AB8</gtr:id><gtr:name>Greifswald University</gtr:name><gtr:address><gtr:line1>Domstra?e 11</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/927046A3-9661-42CB-AFB8-F9171A91DDE8"><gtr:id>927046A3-9661-42CB-AFB8-F9171A91DDE8</gtr:id><gtr:name>College of Medicine, Dentistry &amp; Nursing</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C33876E8-7958-41F0-87A6-095798CF94F9"><gtr:id>C33876E8-7958-41F0-87A6-095798CF94F9</gtr:id><gtr:name>Academy of Sciences of the Czech Republic</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EA377C44-230F-49AB-9191-92C561B03AB8"><gtr:id>EA377C44-230F-49AB-9191-92C561B03AB8</gtr:id><gtr:name>Greifswald University</gtr:name><gtr:address><gtr:line1>Domstra?e 11</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/927046A3-9661-42CB-AFB8-F9171A91DDE8"><gtr:id>927046A3-9661-42CB-AFB8-F9171A91DDE8</gtr:id><gtr:name>College of Medicine, Dentistry &amp; Nursing</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C71DC741-1E1D-4723-A85C-2F40D2DB3F60"><gtr:id>C71DC741-1E1D-4723-A85C-2F40D2DB3F60</gtr:id><gtr:firstName>Julie</gtr:firstName><gtr:surname>Woods</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/BA3A71C5-069C-419B-8925-117C3DBF37D9"><gtr:id>BA3A71C5-069C-419B-8925-117C3DBF37D9</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Sadler</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0701062"><gtr:id>98D7904E-2147-4CFE-A14D-10DB4DEA46D3</gtr:id><gtr:title>Shining new light on drug design: photoactivated chemotherapy</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701062</gtr:grantReference><gtr:abstractText>About 11M cases of cancer are diagnosed each year and there is a pressing need for new anticancer drugs. The world?s leading anticancer drugs are platinum-based compounds such as cisplatin. These types of platinum compounds are not targeted to cancer cells and also kill healthy cells. This can result in severe side-effects and the development of resistance, so that some patients stop responding to treatment. Methods for increasing the selective activation of platinum drugs at the site of the tumour are envisaged which address these problems. We have developed new platinum-based drugs which are non-toxic in the dark, but become highly toxic when activated by light. By shining light only on the area of cancerous tissue, we can target the activation of the drug to just the selected area. 
It is vital that we carry out more studies into how these drugs kill cancer cells, which will involve laboratory work and experiments to investigate if they can shrink/treat cancers. We hope that the wavelengths of light for activating these compounds make them suitable for treating surface cancers and that slight changes to the drugs will allow treatment of a wider range of cancers.</gtr:abstractText><gtr:technicalSummary>With around 25 million people living with a diagnosis of cancer, new anti-cancer therapies are urgently needed. If cancer is to become a manageable disease, then these new therapies need to ensure as few side-effects as possible, and bypass the resistance mechanisms commonly seen with current treatments. In addition, treatments that could be repeated as often as required (unlike current chemotherapy or radiotherapy) would be very useful. Platinum (Pt) drugs are amongst the most successful and commonly prescribed class of anti-cancer agents (44% of 2004 market). Cisplatin and its related prodrug carboplatin have a broad spectra of anti-tumour activity. However, their use is curtailed by the serious dose-limiting side effects that are often responsible for treatment failure. These include extreme nausea and vomiting, ototoxicity and nephrotoxicity. Additionally many tumours have intrinsic or develop acquired resistance to these drugs. The side-effects of Pt drugs could be avoided if a selective activation of a Pt-prodrug could be made to take place only in the tumour tissue. Thus we have developed a series of photolabile Pt(IV) complexes that show equal or greater cytotoxicity than cisplatin tested under identical conditions in cultured tumour cells, but only when they are irradiated with UVA or blue visible light. They are relatively non-toxic in the dark. These photolabile complexes appear to kill the cells by a distinct mechanism and are not simply acting as prodrugs of cisplatin or transplatin. Moreover, they may not require oxygen (O2) for their mechanism of action, thus removing one of the limitations of current, conventional light-activated therapies. Our challenge is to develop Pt-complexes that are selectively taken up by tumour cells, and for which the wavelength of activation can be controlled, making them useful for the treatment of thin walled organs as well as thicker tumours. We also wish to demonstrate antitumour activity without an O2-dependent mechanism. Finally, we want to develop novel methods of light delivery that will optimise the therapeutic benefit of these light-activated Pt prodrugs. Thus the light-activated Pt prodrugs should combine the potent cytotoxic properties of Pt-based drugs, but with the targeting of photodynamic therapy. Success with this project will ultimately lead to more effective and less toxic therapeutics for cancer chemotherapy.</gtr:technicalSummary><gtr:fund><gtr:end>2010-05-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>311798</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Greifswald</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute of Pharmacy Greifswald</gtr:department><gtr:description>Greifswald University</gtr:description><gtr:id>D3D84C50-0B82-4A69-BFE4-40C203A0944D</gtr:id><gtr:impact>A manuscript is in preparation</gtr:impact><gtr:partnerContribution>Provides access to a variety of cancer cell lines for phototoxicity testing; investigation of photinduced DNA binding, effects of glutathione, mechanism of cell cytotoxicity</gtr:partnerContribution><gtr:piContribution>Synthesis of new platinum complexes, characterisation, solution chemistry and biochemistry, investigations of photoactivation and photochemical decomposition pathways.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Warwick</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Life Sciences Warwick</gtr:department><gtr:description>Photoactivated antibiotics</gtr:description><gtr:id>6E710CBE-86A3-450E-A6C2-D3F4B438056E</gtr:id><gtr:impact>Chemistry
Life Sciences</gtr:impact><gtr:partnerContribution>Provision of facilities for culture and assay of bacteria and their growth</gtr:partnerContribution><gtr:piContribution>Synthesis of photoactive ruthenium complexes. Determination of antibacterial activity in the presence and absence of light.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Warwick</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Ultra high resolution mass spectrometry</gtr:description><gtr:id>67C9CDE2-9BA2-40F6-B801-F161867577A7</gtr:id><gtr:impact>Physical chemistry, medicinal inorganic chemistry
Mass spectrometry evidence for cisplatin as a protein cross-linking reagent
H. Li, Huilin, Y. Zhao, H.A. Phillips, Y. Qi, T-Y. Lin, P.J. Sadler, P. O'Connor
Analytical Chem. 2011, 83, 5369-5376.Use of Top-down and Bottom-up Fourier Transform Ion Cyclotron Resonance Mass Spectrometry for Mapping Calmodulin Sites modified by Platinum Anticancer Drug
H. Li , T-Y, Lin , S.L. Van Orden , Y. Zhao , M.P. Barrow , A.M. Pizarro , Y. Qi , P.J. Sadler , and P.B O'Connor
Anal. Chem. 2011, 83, 5369-5376. 

Protein Flexibility is Key to Cisplatin Crosslinking in Calmodulin
H. Li, S.A. Wells, J.E. Jimenez-Roldan, R.A. R&amp;ouml;mer, Y. Zhao, P.J. Sadler, P.B. O'Connor
Protein Science 2012, 21, 1269-1279.

Mapping the Protein-Binding Sites for Novel Iridium(III) Anticancer Complexes Using Electron Capture Dissociation
Y. Qi, Z. Liu, H. Li, P.J. Sadler, P.B. O'Connor
Rapid Comm. Mass Spec. 2013, 27, 2028-2032.

Insights into the Binding Sites of Organometallic Ruthenium
Anticancer Compounds on Peptides Using Ultra-High
Resolution Mass Spectrometry
R.H. Wills, A. Habtemariam, A.F. Lopez-Clavijo, M.P. Barrow,
P.J. Sadler, P.B. O'Connor
J. Am. Soc. Mass Spectrom. 2014, 25, 662-672.

Mass Spectrometric Strategies to Improve the Identification of Pt(II)-Modification Sites on Peptides and Proteins
H. Li, Huilin, J.R. Snelling, M.P. Barrow, P.J.Sadler, P. O'Connor
J. Amer. Soc. Mass Spec. 2014, 25. 1217-1227.</gtr:impact><gtr:partnerContribution>Characterisation of metallodrugs and their adducts with DNA, oligonucleotides, proteins and peptides by FT ICR MS, including the use ofseparation by nanoHPLC and a variety of ion fragmentation techniques</gtr:partnerContribution><gtr:piContribution>Synthesis and reactions of organometallic and photoactivated anticancer metal complexes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Academy of Sciences of the Czech Republic</gtr:collaboratingOrganisation><gtr:country>Czech Republic</gtr:country><gtr:department>Institute of Biophysics</gtr:department><gtr:description>Czech Academy of Sciences</gtr:description><gtr:id>29755CB1-20E6-49C4-96DA-A1E768341440</gtr:id><gtr:impact>Warwick iCast: http://www2.warwick.ac.uk/newsandevents/icast/archive/s2week15/platinum/</gtr:impact><gtr:partnerContribution>Access to a wide range of advanced biophysical techniques and methods, especially aimed at characterisation of DNA adducts</gtr:partnerContribution><gtr:piContribution>Synthesis of new platinum complexes, characterisation, solution chemistry and biochemistry, investigations of photoactivation and photochemical decomposition pathways.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>College of Medicine, Dentistry &amp; Nursing</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Dermatology and Genetic Medicine</gtr:department><gtr:description>Photobiology studies of new Pt(IV) anticancer drugs</gtr:description><gtr:id>3344A345-66EA-4E7D-BC63-2C71C47217F6</gtr:id><gtr:impact>Warwick iCast: http://www2.warwick.ac.uk/newsandevents/icast/archive/s2week15/platinum/ Publications: 18093923, 19290364, 19994893</gtr:impact><gtr:partnerContribution>Specialist photobiological facilities</gtr:partnerContribution><gtr:piContribution>Synthesis of new platinum complexes, characterisation, solution chemistry and biochemistry, investigations of photoactivation and photochemical decomposition pathways.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit - Coventry</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E3B73E97-B35A-46D5-800A-968A5DECF00C</gtr:id><gtr:impact>Teaching Fellow in Chemistry at Warwick, presented our work on light activated platinum anti-cancer complexes at Bablake School, Coventry

Stimulates the interest of school pupils in science and its medicial applications.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - Fairford</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BC8D20DE-9872-4D8C-BE23-23CE68135D51</gtr:id><gtr:impact>Teaching Fellow in Chemistry at Warwick, presented our work on light activated platinum anti-cancer complexes at Farmors School, Fairford, Gloucestershire - talk given twice. The age of the audiences ranges from 16 - 18 (occasionally to 12 years old)

Stimulates the interest of school pupils in science and its medicial applications.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - Redditch</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D10E3406-813E-44CF-B936-B888245B42E9</gtr:id><gtr:impact>Teaching Fellow in Chemistry at Warwick, presented our work on light activated platinum anti-cancer complexes at Kingsley College, Redditch. The age of the audiences ranges from 16 - 18 (occasionally to 12 years old)

Stimulates the interest of school pupils in science and its medicial applications.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - Coventry</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4DF259D7-0CAE-41C6-82A2-8D3876C70AD5</gtr:id><gtr:impact>Teaching Fellow in Chemistry at Warwick, presented our work on light activated platinum anti-cancer complexes at The Grange Extended Learning Centre, Coventry

Stimulates the interest of school pupils in science and its medicial applications.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - Cirencester</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9405D93F-BDE4-47E5-995B-236611770ED1</gtr:id><gtr:impact>Teaching Fellow in Chemistry at Warwick, presented our work on light activated platinum anti-cancer complexes at Deer Park School, Cirencester, Glos.

Stimulates the interest of school pupils in science and its medicial applications.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - Kenilworth</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>2F52BE85-EEDD-4087-9BEB-DEB516D13EBC</gtr:id><gtr:impact>Teaching Fellow in Chemistry at Warwick, presented our work on light activated platinum anti-cancer complexes at Kenilworth School

Stimulates the interest of school pupils in science and its medicial applications.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - High Wycombe</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B52530BB-0C09-4711-9153-EBEC39AB310E</gtr:id><gtr:impact>Teaching Fellow in Chemistry at Warwick, presented our work on light activated platinum anti-cancer complexes at Wycombe Abbey School, High Wycombe

Stimulates the interest of school pupils in science and its medicial applications.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PJS Website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>138E240F-9F94-467C-BC17-E56E5ED5D5EB</gtr:id><gtr:impact>We maintain a lab website which gives details of our publications and new developments relating to this project http://www2.warwick.ac.uk/fac/sci/chemistry/research/chemicalbiology/sadler/sadlergroup/

Contact from many interested people.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www2.warwick.ac.uk/fac/sci/chemistry/research/chemicalbiology/sadler/sadlergroup/</gtr:url><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - Coventry</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>56257751-B1EF-44E8-A9B8-DCF8D226E42B</gtr:id><gtr:impact>Teaching Fellow in Chemistry at Warwick, presented our work on light activated platinum anti-cancer complexes at The Westwood School, Coventry

Stimulates the interest of school pupils in science and its medicial applications.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - Rugby</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C00FC857-4528-459F-9F98-5F7C776037BD</gtr:id><gtr:impact>Teaching Fellow in Chemistry at Warwick, presented our work on light activated platinum anti-cancer complexes at Rugby School

Stimulates the interest of school pupils in science and its medicial applications.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC DTA (MOAC)</gtr:description><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>982654BB-1F0A-412A-B46A-077A08A9C818</gtr:id><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1315811</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Research Council</gtr:description><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:fundingRef>247450</gtr:fundingRef><gtr:id>5C2D2958-3656-4A1A-B009-E0BD8A3549AC</gtr:id><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>418100</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Project Grant EP/G006792/1 Photoactivation strategies for delivery of platinum prodrugs; oxygen independent photodynamic therapy (PDT)</gtr:description><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/G006792/1</gtr:fundingRef><gtr:id>C9775940-22F6-43A0-B222-1448EDEA8318</gtr:id><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Modulator for a Pharmacological Agent</gtr:description><gtr:id>8E393067-256F-4A05-B5C3-EF8839BF88C0</gtr:id><gtr:impact>Modulator for a Pharmacological Agent</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>GB1215498.5</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Modulator for a Pharmacological Agent</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/43D5807A-1029-46E5-8ED7-6998DF222203"><gtr:id>43D5807A-1029-46E5-8ED7-6998DF222203</gtr:id><gtr:title>Spin-labelled photo-cytotoxic diazido platinum(iv) anticancer complex.</gtr:title><gtr:parentPublicationTitle>Dalton transactions (Cambridge, England : 2003)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/84743cd573b2d09f9cf1a56b00f4fab8"><gtr:id>84743cd573b2d09f9cf1a56b00f4fab8</gtr:id><gtr:otherNames>Venkatesh V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1477-9226</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/26C9CB7E-8794-4DD3-9503-2F3AF3D86C5C"><gtr:id>26C9CB7E-8794-4DD3-9503-2F3AF3D86C5C</gtr:id><gtr:title>Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine.</gtr:title><gtr:parentPublicationTitle>Dalton transactions (Cambridge, England : 2003)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4be7d9884cbff2c6e44b8246c9910410"><gtr:id>4be7d9884cbff2c6e44b8246c9910410</gtr:id><gtr:otherNames>Farrer NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1477-9226</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DA593C62-639A-4EBC-9AC8-45753B34B5F0"><gtr:id>DA593C62-639A-4EBC-9AC8-45753B34B5F0</gtr:id><gtr:title>Wiley Encyclopedia of Chemical Biology</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e3ade42c34f8da1d821e0190e2ef6b8b"><gtr:id>e3ade42c34f8da1d821e0190e2ef6b8b</gtr:id><gtr:otherNames>Mukherjee A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5CDF6B5D-DB05-4910-AA83-DF30534D01D8"><gtr:id>5CDF6B5D-DB05-4910-AA83-DF30534D01D8</gtr:id><gtr:title>A Photoactivatable Platinum(IV) Anticancer Complex Conjugated to the RNA Ligand Guanidinoneomycin.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f8990160e5fec2a60d77343b9eac664d"><gtr:id>f8990160e5fec2a60d77343b9eac664d</gtr:id><gtr:otherNames>Shaili E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0EEAC434-46C7-4AD2-AEE5-044D2E3C8447"><gtr:id>0EEAC434-46C7-4AD2-AEE5-044D2E3C8447</gtr:id><gtr:title>Synthesis, characterisation and photochemistry of Pt(IV) pyridyl azido acetato complexes.</gtr:title><gtr:parentPublicationTitle>Dalton transactions (Cambridge, England : 2003)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c6b178e184bcd1de3b103151c80617fc"><gtr:id>c6b178e184bcd1de3b103151c80617fc</gtr:id><gtr:otherNames>Mackay FS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1477-9226</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7CC2B872-29F6-4D7E-894A-B38D7B36C9EE"><gtr:id>7CC2B872-29F6-4D7E-894A-B38D7B36C9EE</gtr:id><gtr:title>Photochemistry in photonic crystal fiber nanoreactors.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0d7ee71c25291f2dd45eecef304b4874"><gtr:id>0d7ee71c25291f2dd45eecef304b4874</gtr:id><gtr:otherNames>Chen JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5E2F15BC-20FD-46A7-A16B-C8F558C2E16B"><gtr:id>5E2F15BC-20FD-46A7-A16B-C8F558C2E16B</gtr:id><gtr:title>Photocytotoxic trans-diam(m)ine platinum(IV) diazido complexes more potent than their cis isomers.</gtr:title><gtr:parentPublicationTitle>Chemical research in toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4be7d9884cbff2c6e44b8246c9910410"><gtr:id>4be7d9884cbff2c6e44b8246c9910410</gtr:id><gtr:otherNames>Farrer NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0893-228X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4D91CDBD-D2EF-4740-8A1B-E65945FF494D"><gtr:id>4D91CDBD-D2EF-4740-8A1B-E65945FF494D</gtr:id><gtr:title>Photoactivation of trans diamine platinum complexes in aqueous solution and effect on reactivity towards nucleotides.</gtr:title><gtr:parentPublicationTitle>Journal of inorganic biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5239041b28b67ddcf728e869f627d4ae"><gtr:id>5239041b28b67ddcf728e869f627d4ae</gtr:id><gtr:otherNames>Cubo L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0162-0134</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DB096725-E4D1-49A5-9A0D-2DA1BF61F58B"><gtr:id>DB096725-E4D1-49A5-9A0D-2DA1BF61F58B</gtr:id><gtr:title>Photoinduced reactions of cis,trans,cis-[Pt(IV)(N3)2(OH)2(NH3)2) with 1-methylimidazole.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2f385764d6c062d45c3015473e7ca215"><gtr:id>2f385764d6c062d45c3015473e7ca215</gtr:id><gtr:otherNames>Phillips HI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F28A8AED-6CC5-4200-AD73-F44FE067DE1F"><gtr:id>F28A8AED-6CC5-4200-AD73-F44FE067DE1F</gtr:id><gtr:title>Cytotoxicity, hydrophobicity, uptake, and distribution of osmium(II) anticancer complexes in ovarian cancer cells.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/184980c1920bd6005f07f658ff28193b"><gtr:id>184980c1920bd6005f07f658ff28193b</gtr:id><gtr:otherNames>van Rijt SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7CA426C7-7E8F-4CFE-B0C1-16C80C3FEFBA"><gtr:id>7CA426C7-7E8F-4CFE-B0C1-16C80C3FEFBA</gtr:id><gtr:title>Cellular accumulation, lipophilicity and photocytotoxicity of diazido platinum(IV) anticancer complexes.</gtr:title><gtr:parentPublicationTitle>ChemMedChem</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/67f056c3713dc9714b0e9490f776ba7d"><gtr:id>67f056c3713dc9714b0e9490f776ba7d</gtr:id><gtr:otherNames>Pizarro AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1860-7179</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C2DFC90E-A377-4B68-ABED-74B179FC70F2"><gtr:id>C2DFC90E-A377-4B68-ABED-74B179FC70F2</gtr:id><gtr:title>Excited-State Dynamics of a Two-Photon-Activatable Ruthenium Prodrug.</gtr:title><gtr:parentPublicationTitle>Chemphyschem : a European journal of chemical physics and physical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/37677a3a3f97a7d5ebb939ecf6f06f5c"><gtr:id>37677a3a3f97a7d5ebb939ecf6f06f5c</gtr:id><gtr:otherNames>Greenough SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1439-4235</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/83BF085E-6969-40EF-B6C2-A9C0AECC6D2A"><gtr:id>83BF085E-6969-40EF-B6C2-A9C0AECC6D2A</gtr:id><gtr:title>A potent cytotoxic photoactivated platinum complex.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c6b178e184bcd1de3b103151c80617fc"><gtr:id>c6b178e184bcd1de3b103151c80617fc</gtr:id><gtr:otherNames>Mackay FS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2EFEE579-9EF6-4882-A874-B98D3FAA0B70"><gtr:id>2EFEE579-9EF6-4882-A874-B98D3FAA0B70</gtr:id><gtr:title>Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: a light-activated antitumor platinum complex that kills human cancer cells by an apoptosis-independent mechanism.</gtr:title><gtr:parentPublicationTitle>Molecular cancer therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8d438e49263d60c757e281eb04b7b124"><gtr:id>8d438e49263d60c757e281eb04b7b124</gtr:id><gtr:otherNames>Westendorf AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1535-7163</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C3D317C3-D00C-4F5E-9E5A-38A6D64B1FAC"><gtr:id>C3D317C3-D00C-4F5E-9E5A-38A6D64B1FAC</gtr:id><gtr:title>Unusual DNA binding modes for metal anticancer complexes.</gtr:title><gtr:parentPublicationTitle>Biochimie</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/67f056c3713dc9714b0e9490f776ba7d"><gtr:id>67f056c3713dc9714b0e9490f776ba7d</gtr:id><gtr:otherNames>Pizarro AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0300-9084</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E9ED699B-8ECC-4768-83A4-0ABFDF37A4D0"><gtr:id>E9ED699B-8ECC-4768-83A4-0ABFDF37A4D0</gtr:id><gtr:title>Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs.</gtr:title><gtr:parentPublicationTitle>Drug discovery today</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/184980c1920bd6005f07f658ff28193b"><gtr:id>184980c1920bd6005f07f658ff28193b</gtr:id><gtr:otherNames>van Rijt SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1359-6446</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2359CE0B-9D22-4304-91D4-4CF7962441C3"><gtr:id>2359CE0B-9D22-4304-91D4-4CF7962441C3</gtr:id><gtr:title>Ultrafast photo-induced ligand solvolysis of cis-[Ru(bipyridine)2(nicotinamide)2](2+): experimental and theoretical insight into its photoactivation mechanism.</gtr:title><gtr:parentPublicationTitle>Physical chemistry chemical physics : PCCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/37677a3a3f97a7d5ebb939ecf6f06f5c"><gtr:id>37677a3a3f97a7d5ebb939ecf6f06f5c</gtr:id><gtr:otherNames>Greenough SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1463-9076</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5C286BCF-CD74-47B6-9A32-B74D021B1EF1"><gtr:id>5C286BCF-CD74-47B6-9A32-B74D021B1EF1</gtr:id><gtr:title>Photochemotherapy: Targeted Activation of Metal Anticancer Complexes</gtr:title><gtr:parentPublicationTitle>Australian Journal of Chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cf843c6a2035b60da621abb3cc2ac3ca"><gtr:id>cf843c6a2035b60da621abb3cc2ac3ca</gtr:id><gtr:otherNames>Farrer N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6BBE2A1B-9F95-43BD-9B57-1CF2283C043D"><gtr:id>6BBE2A1B-9F95-43BD-9B57-1CF2283C043D</gtr:id><gtr:title>Controlling Platinum, Ruthenium and Osmium Reactivity for Anticancer Drug Design.</gtr:title><gtr:parentPublicationTitle>Advances in inorganic chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c2dd79c9dd0a4da5efa5dd95dc7e2f0a"><gtr:id>c2dd79c9dd0a4da5efa5dd95dc7e2f0a</gtr:id><gtr:otherNames>Bruijnincx PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0898-8838</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/238A8330-4280-4F9D-B658-D3118017138A"><gtr:id>238A8330-4280-4F9D-B658-D3118017138A</gtr:id><gtr:title>An integrin-targeted photoactivatable Pt(IV) complex as a selective anticancer pro-drug: synthesis and photoactivation studies.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fdcac558fe5ac560f214ae332b25b04f"><gtr:id>fdcac558fe5ac560f214ae332b25b04f</gtr:id><gtr:otherNames>Gandioso A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FA6BB269-D961-4EC6-8227-9038F91FC114"><gtr:id>FA6BB269-D961-4EC6-8227-9038F91FC114</gtr:id><gtr:title>New trends for metal complexes with anticancer activity.</gtr:title><gtr:parentPublicationTitle>Current opinion in chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c2dd79c9dd0a4da5efa5dd95dc7e2f0a"><gtr:id>c2dd79c9dd0a4da5efa5dd95dc7e2f0a</gtr:id><gtr:otherNames>Bruijnincx PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1367-5931</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F495BC73-70C6-4974-80EA-39B6EA5747C8"><gtr:id>F495BC73-70C6-4974-80EA-39B6EA5747C8</gtr:id><gtr:title>A potent trans-diimine platinum anticancer complex photoactivated by visible light.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4be7d9884cbff2c6e44b8246c9910410"><gtr:id>4be7d9884cbff2c6e44b8246c9910410</gtr:id><gtr:otherNames>Farrer NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7B602DA0-FE7A-4264-A9B1-4961B8F54A33"><gtr:id>7B602DA0-FE7A-4264-A9B1-4961B8F54A33</gtr:id><gtr:title>Microfluidic integration of photonic crystal fibers for online photochemical reaction analysis.</gtr:title><gtr:parentPublicationTitle>Optics letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/896b72640b1dc79e65e98c1050055698"><gtr:id>896b72640b1dc79e65e98c1050055698</gtr:id><gtr:otherNames>Unterkofler S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0146-9592</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/42E74404-0BDE-4A5F-B09A-0687AC5E5AF8"><gtr:id>42E74404-0BDE-4A5F-B09A-0687AC5E5AF8</gtr:id><gtr:title>Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: a light-activated antitumor platinum complex that kills human cancer cells by an apoptosis-independent mechanism.</gtr:title><gtr:parentPublicationTitle>Molecular cancer therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8d438e49263d60c757e281eb04b7b124"><gtr:id>8d438e49263d60c757e281eb04b7b124</gtr:id><gtr:otherNames>Westendorf AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1535-7163</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701062</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>006DC612-6329-4D37-A540-5FB2CA634720</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.5  Radiotherapy</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>